Why 340,000 Americans With Chronic Sciatica Are Walking Away From Their Surgery Date This Year, Without Paying for a $52,000 Spinal Fusion

By Karen Whitfield

Health & Consumer Affairs Reporter · June 2026

I didn't set out to write about back pain devices.

I cover consumer health fraud. For the past three weeks, I've been looking into something that doesn't usually cross my desk: a pattern of people canceling scheduled spinal surgery, not because the pain went away on its own, but because they found something else first and decided to wait and see.

That's a strange thing for a chronic pain patient to do. By the time most people get a fusion date on the calendar, they want it over with. Canceling means betting your continued suffering on something unproven.

So when readers started forwarding me the same story, a retired spine surgeon, his wife, an eighteen-month ordeal, I assumed I'd find the catch within an hour.

It took me three weeks to find out there wasn't one I could prove.

What's Actually Driving This

The CDC estimates more than sixteen million American adults live with chronic low back pain or sciatica. A 2025 evidence review in BMJ Evidence-Based Medicine, covering 301 trials, found that only about one in ten non-surgical treatments produce a meaningful reduction in pain. And the outcome data on spinal fusion, the $50,000-plus procedure typically offered when everything else fails, is worse than most patients are told: published research puts the rate of persistent post-surgical pain between 10 and 40 percent. It's common enough to have its own clinical name: Failed Back Surgery Syndrome.

I called Dr. Renata Okafor, a physiatrist specializing in non-surgical spine and nerve pain with no relationship to the company at the center of this story, and asked her why a "successful" surgery so often leaves people in the same pain.

I asked her to explain it to me the way she'd explain it to a patient.

I asked her directly: does surgery address that loop?

I asked her why, if this is established physiology, it isn't part of the standard conversation before someone signs a consent form.

That's not a conspiracy. It's a gap. But it's a gap that, according to the people I spoke to, is costing patients years.

The Surgeon Who Says He Missed It For Thirty-Two Years

I requested an interview with Dr. Robert Hartwell, a retired spine surgeon who spent thirty-two years at the Cleveland Clinic and performed an estimated three thousand operations. I confirmed his licensure and surgical history through public state medical board records before agreeing to the interview.

I'll say upfront: when a source offers you his own wife as a witness, I treat that as a reason for more scrutiny, not less. This one didn't sound staged.

Margaret Hartwell had been dealing with sciatica for over a year and a half. I asked her to walk me through everything she'd tried, in order, not the highlight reel.

I asked Dr. Hartwell why, if the loop Dr. Okafor described is real and well documented, it took his own wife's suffering for him to focus on it.

That question is what sent his son, a biomedical engineer, digging through the research for three days.

What an Engineer Found That a Surgeon Hadn't

Daniel Hartwell spent twenty-two years designing medical devices, including heat-therapy and ultrasound equipment used inside physical therapy clinics. I asked him to explain, in plain terms, what he found and what he built, and to be specific about what it does and doesn't claim to do.

I asked where the idea of using light to address that came from.

I asked why a drugstore heating pad doesn't solve this.

The three things he described, deep heat, mechanical vibration, and red and near-infrared light, map onto three of the four sides of Dr. Okafor's loop: heat restores blood flow, vibration helps clear the trapped waste once circulation resumes, and the light targets the fourth side, recharging the depleted cells so the muscle can actually release.

None of the three is individually new. What hadn't been done was combine all four points of intervention into something a patient could use unsupervised, at home.

I asked him directly whether the device is meant to replace medical care or a surgical evaluation.

I put that distinction to Dr. Okafor directly, without naming the product, and asked whether combining heat, vibration, and light into one device for home use was legitimate engineering or a repackaging of nothing new.

She added a caveat I want to keep front and center.

What the Same Mechanism Costs Everywhere Else

Before I tell you what Daniel Hartwell did next, I wanted to know what it costs to get this kind of treatment through normal channels, because if the loop Dr. Okafor described is real, somebody is already charging for access to the technology that addresses it.

They are.

And that's assuming you can get an appointment. Patients and providers told me the average wait for a new PT evaluation runs eight to sixteen weeks.

So the honest comparison isn't "pills versus device." It's that the technology addressing this loop is already sold, in clinics, for thousands of dollars and months of waiting. The question wasn't whether heat, vibration, and light could interrupt the cycle, multiple sources told me that wasn't seriously in dispute. The question was why nobody had made it possible to do at home.

The Kitchen Table

That's the question Daniel Hartwell says he couldn't stop turning over after his father called him about Margaret.

He drove up that weekend with research papers and a laptop, and spent three days going through clinical guidelines and the same mitochondrial-function and photobiomodulation research Dr. Okafor later confirmed for me independently as legitimate, if still developing, science.

By Sunday, he had a working theory and a question for his father that no one had asked him in three decades of practice: why does the clinic have equipment that addresses all four sides of that loop at once, while the patient goes home with a pill bottle and a sheet of stretches that, at best, touches one side of it?

He came back the following weekend with a prototype, not a product, a proof of concept.

Margaret was skeptical. She'd already been through Voltaren gel, Tiger Balm, a copper compression sleeve, and a drugstore heating pad, none of which had done anything. She agreed because her son had driven up two weekends in a row.

I'll admit I went into these interviews assuming I'd find the same thing I usually find in these stories: a financial stake, an emotionally compelling spouse, a mechanism vague enough to sound plausible without being checkable. What kept me reporting instead of walking away was Dr. Okafor's answer when I asked her, off the cuff, whether I was wasting my time.

That's why I kept going instead of stopping at "the mechanism checks out."

What Happened After Margaret Tried It

Her son built the first version on her kitchen table, after watching her go through everything else. She told me she was skeptical herself, she'd already tried a drugstore heating pad, a copper sleeve, and topical gel, all with no real effect.

I asked her directly whether she'd considered this could be coincidence rather than the device.

That's not proof. It's a reasonable, falsifiable answer from someone willing to entertain the alternative, which is more than I can say for most testimonials I've sat through in this job.

The Customers I Called Myself

The company gave me contact information for several customers, with permission to reach out, a company-selected sample, not a random one.

A retired mail carrier in Ohio told me he'd stopped a yearly fishing trip for three years because of his back, and made the trip again six weeks after starting the device. A retired charge nurse of thirty-one years in an orthopedic unit, who'd administered the standard pain protocol for three decades before needing it herself, called herself "the most skeptical person they could have sold this to." A woman in Indianapolis bought it for her seventy-one-year-old mother, who'd been on a sixteen-month waitlist for a microdiscectomy; three months later, her mother's surgeon agreed to re-evaluate and hold off on the operation.

I have no way to independently verify the surgical scheduling claims beyond what each person told me. I'm reporting them as personal accounts, not confirmed medical outcomes.

The company also shared aggregate, company-administered survey data, self-reported, not independently audited. According to that data:

That answer did more for his credibility with me than a glossier one would have.

The Device Itself

What Daniel Hartwell eventually built, and what the company now sells, is a cordless belt that straps around the lower back. It's called the Revornyn ThermaPro. It combines targeted heat (adjustable up to 150°F), pulsing vibration massage, and red and near-infrared light into a single device designed to address all four sides of the loop at once, for fifteen minutes of daily use, without a prescription.

How It Works: 3 Steps, 15 Minutes

1

Strap It On

Wrap the cordless belt around your lower back, right over where the nerve gets strangled. Adjusts to any waist.

2

Press & Set

One button powers it on. Deep heat, pulsing massage, and red and near-infrared light switch on together.

3

Sit Back

Relax in your own chair while heat and vibration reach the deep muscle and the light recharges the cells. Then go on with your day.

Just 15 min / day

I want to be precise about what I am and am not saying. I'm not saying this cures sciatica, or that it's a substitute for a surgeon's judgment about whether you need an operation. Dr. Okafor's caution is the right caution: there's no independent clinical trial behind this specific device, and anyone telling you otherwise is overstating the evidence.

What I'm willing to put my name on is narrower: the underlying mechanism, a four-part loop in which a locked muscle, cut-off circulation, trapped waste, and energy-depleted cells reinforce each other, and surgery only ever addresses one side of it, held up under questioning from an independent physician with nothing to gain from the answer. So did the idea that heat, circulation support, and light-based cellular stimulation target the loop in a way oral medication structurally cannot. The credentials are real. The company let me ask adversarial questions and didn't restrict who I could call.

For comparison: against the costs I found for the standard pathway, north of $11,000 over eighteen months in Margaret's case, before the $52,000 fusion was even scheduled, the company prices the device at $99 during its current run, with a 90-day refund policy.

The Part the Company Was Surprisingly Specific About

I asked Revornyn Health for actual production numbers, expecting the vague "limited stock" language I see on every page like this.

They gave me real figures. Current production capacity runs around 800 units a week through their U.S. manufacturing partner, the same facility that produces heating elements for clinical-grade PT equipment, Daniel said, not a separate, cheaper line. Order volume is running ahead of that; at the time of my last call, they had roughly 2,400 units in their Ohio warehouse.

I asked why they don't scale production to meet demand.

That's why the company has periodic stock-out windows rather than a waitlist. I confirmed this by checking the page over several days; on two of those days, it showed unavailable.

One reader in Pennsylvania told me she'd meant to order it the week she first saw it, decided to think it over, and came back ten days later to find it sold out.

I'm not including that to manufacture urgency. I'm including it because it's the most honest answer I got to a question I ask every company I report on: what happens to the people who wait. Here, the answer is they wait for the next batch, not that the company invents a fake countdown. Whether that's a meaningful distinction is something I'll let you decide.

What I'd Tell Someone Asking Me Directly

If you have a scheduled surgery date, I'm not telling you to cancel it. Talk to your surgeon about your specific imaging. Ask directly whether your case requires structural repair, or whether a trial period addressing the muscle and circulation might reasonably be tried first, under supervision.

If your doctor says there's no urgent reason you can't wait and observe, and you want something to use alongside your existing care rather than instead of it, this is the most credible version of this category I've encountered in eleven years of writing about consumer health claims. The 90-day refund window means you're not taking on real financial risk to find out if it helps you.

That's a narrower claim than the company's own marketing makes. It's the only one I'm willing to make myself.

A note on safety, because Dr. Okafor was firm about it. Some people genuinely need the operation. If you've lost control of your bladder, or your foot drags when you walk, that's past sciatica, and you belong in a hospital today, not reading this. The ThermaPro is not a diagnosis or a substitute for surgical judgment. Always talk to your own doctor before changing any medication, especially gabapentin or Lyrica, which need a gradual taper.

Readers Who Wrote In

Frequently Asked Questions